Denosumab 低血鈣症風險評分計算機 (停經後骨質疏鬆症)

Score card for hypocalcemia followed by denosumab

Blood Corrected Calcium (mg/dL) :
估算腎絲球過濾率 [eGFR] (mL/min/1.73 m²) :

High risk group
– Patients without CKD & corrected Ca < 8.5
– Patients with CKD & corrected Ca < 9.5

Reference :
Kim,K.J., Hong,N., Lee,S., Kim,M., & Rhee,Y.(2020). A Simple-to-Use Score for Identifying Individuals at High Risk of Denosumab-Associated Hypocalcemia in Postmenopausal Osteoporosis: A Real-World Cohort Study. Calcified Tissue International, 107(6), 567-575.